glp-1 dpp 4 combination Effect of training in with DPP-4 inhibition (with Dipeptidyl peptidase 4 inhibitors in

MLM received lecture or consultancy fees from Amarin, Amgen, AstraZeneca, Eli Lilly, MSD, Novo Nordisk, SlaPharma, and Servier

There are no commercially available GLP-1 agonist containing patches

Patients who were prescribed other GLP-1RAs or had bariatric surgery on or before the index event were excluded

Many people regain weight if they stop GLP-1s without lasting lifestyle changes in place

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers